Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1988 Dec 17;297(6663):1560–1561. doi: 10.1136/bmj.297.6663.1560

Duodenal ulcers that are difficult to heal.

R Pounder 1
PMCID: PMC1835295  PMID: 2906259

Full text

PDF
1560

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardhan K. D. Refractory duodenal ulcer. Gut. 1984 Jul;25(7):711–717. doi: 10.1136/gut.25.7.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berstad A., Aadland E., Bjerke K. Cimetidine treatment of recurrent ulcer after proximal gastric vagotomy. Scand J Gastroenterol. 1981;16(7):891–896. doi: 10.3109/00365528109181819. [DOI] [PubMed] [Google Scholar]
  3. Bianchi Porro G., Parente F., Lazzaroni M. Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers. Gut. 1987 Jul;28(7):907–911. doi: 10.1136/gut.28.7.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chiverton S. G., Hunt R. H. Medical regimens in short- and long-term ulcer management. Baillieres Clin Gastroenterol. 1988 Jul;2(3):655–676. doi: 10.1016/s0950-3528(88)80012-5. [DOI] [PubMed] [Google Scholar]
  5. Lam S. K., Lee N. W., Koo J., Hui W. M., Fok K. H., Ng M. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine. Gut. 1984 Jul;25(7):703–706. doi: 10.1136/gut.25.7.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Merki H. S., Witzel L., Walt R. P., Neumann J., Scheurle E., Kaufmann D., Mappes A., Heim J., Röhmel J. Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients. Aliment Pharmacol Ther. 1987 Jun;1(3):217–223. doi: 10.1111/j.1365-2036.1987.tb00621.x. [DOI] [PubMed] [Google Scholar]
  7. Mignon M., Bonfils S. Diagnosis and treatment of Zollinger-Ellison syndrome. Baillieres Clin Gastroenterol. 1988 Jul;2(3):677–698. doi: 10.1016/s0950-3528(88)80013-7. [DOI] [PubMed] [Google Scholar]
  8. Newman R. D., Gitlin N., Lacayo E. J., Safdi A. V., Ramsey E. J., Engel S. L., Rubin A., Nissen C. H., Swabb E. A. Misoprostol in the treatment of duodenal ulcer refractory to H2-blocker therapy. A placebo-controlled, multicenter, double-blind, randomized trial. Am J Med. 1987 Jul 27;83(1A):27–31. doi: 10.1016/0002-9343(87)90575-4. [DOI] [PubMed] [Google Scholar]
  9. Primrose J. N., Axon A. T., Johnston D. Highly selective vagotomy and duodenal ulcers that fail to respond to H2 receptor antagonists. Br Med J (Clin Res Ed) 1988 Apr 9;296(6628):1031–1035. doi: 10.1136/bmj.296.6628.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tytgat G. N., Lamers C. B., Hameeteman W., Jansen J. M., Wilson J. A. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists. Aliment Pharmacol Ther. 1987 Feb;1(1):31–38. doi: 10.1111/j.1365-2036.1987.tb00603.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES